"Discovery2" Study of Using MCG at Emergency Departments

Part of paid clinical trials in San Francisco, California.

Sponsor
SB Technology, Inc.
Study ID
NCT07822581
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Acute Coronary Syndromes (ACS)
  • Chest Pain
  • Coronary Artery Disease (CAD)
  • NSTE-ACS (NSTEMI and UA)

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Magnetocardiography — DEVICE
    The SandboxAQ CardiAQ System is an investigational device, and it is intended to non-invasively measure and display the magnetic signals produced by the electric currents in the heart. Its purpose is to assist in the evaluation of myocardial ischemia and infarction risks, in patients with symptoms suggestive of ACS. It is intended to complement clinical judgment and to augment standard of care diagnostic tools.

Study Details

The purpose of this research is to collect the magnetic signals from the heart to identify features that may help Emergency Department (ED) doctors differentiate high and low risk patients for heart related chest pain.

Key Dates

First listed
Sep 16, 2026
Start date
Sep 1, 2026
Status verified
Aug 2026
Primary completion
Feb 28, 2027
Completion
Mar 30, 2027

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Training machine learning algorithms. [ Time Frame: Up to 30 Days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UCSF - Zuckerberg San Francisco General Hospital and Trauma CenterSan FranciscoCalifornia94143
Katherine Steineman
707-718-3130
Lucas Zier, MD, MS (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

Related Studies